The UK Intellectual Property Office granted 2nd of March 2016 the UK patent for Luer-Jack Lock. The patent is the frontrunner for similar filed applications (pending) in all important markets world wide and is a fundamental member of the Luer-Jack patent family, ensuring a very simple one-hand operated release of connections for different fluid transfer applications.
The Board of Directors of ConceptoMed AS announce the private placement of equity in ConceptoMed AS. Following the share issue, the number of Shareholders in the company amounts to 73 (previously 37). Gross proceeds from the private placement amounts to NOK 89.056.000 (approx. 9,4 MEUR), whereof 25,5 MNOK were subscribed by existing shareholders.
Since April 2012, Dehns has drafted and filed over 50 patent applications across 8 families, as well as a number of design registrations and trade marks. Patents have so far been granted in 4 families, and applications are pending in a number of territories including UK & Europe, PCT, USA, Brazil, Argentina, Australia, China, Hong Kong, India, South Korea, Singapore, Japan, Mexico, and Russia.
LUER-JACK APPROVED FOR SALE & MARKETING IN EUROPE (CE mark)
FIRST ORDERS OF LUER-JACK SHIPPING AFTER CE-MARK APPROVAL
ConceptoMed today announced that the company has received CE Mark approval for the Luer-Jack® syringe, a new and innovative medical syringe. Luer-Jack® is now ready for the European market and other large markets, where the CE mark allows for market entry.
From June 2014 to July 2015, The Norwegian Research Council (VRI) supported an evaluation research study on Luer-Jack®, a new medical syringe with one-hand disconnection from needles/cannulas and luer type connections. The Intervention Centre of Oslo University Hospital has conducted the study, and the final report was submitted to ConceptoMed today, 1st of September 2015.
The Norwegian Minister of Health Bent Høie will see how medical equipment in a simple and efficient way can increase quality for a large number of medical procedures. ConceptoMed is moving front stage to initiate and elevate focus on quality during the billions of small procedures being executed worldwide.